Skip to content
Back to Guavy Wire
Crypto

Injective Surges on Buyback, USDC Migration Amid Broad Crypto Rally

Instruments
BTC USDC ATOM INJ
Share

The price of Injective (INJ) surged by 3.5% over the past 42 hours due to several bullish catalysts.

One key factor was the community buyback program, which directs protocol revenue and ecosystem funds into buying back INJ on the market. The September Community BuyBack reached full participation on August 26, 2026, with more than $168,000 committed to buying INJ.

Another catalyst was Injective's role in the Cosmos/DeFi stack, particularly around USDC and on-chain activity. A recent announcement stated that Injective will migrate legacy USDC representations into a canonical 'Injective USDC' standard in September 2026, in collaboration with Circle and teams across the Cosmos ecosystem.

The move in INJ also coincided with a broader risk-on rally driven by Bitcoin's strong performance. Over the same period, Bitcoin pushed above $80,000 on August 25, 2026, with dominance rising and ETFs seeing some of their best weekly net inflows since late 2025.

More on Crypto

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc